New Zealand curler
POPULARITY
Categories
In this episode, Scott Becker reflects on how highly critical people are often those who have achieved the least, while successful and confident individuals tend to be more supportive and encouraging.
In this episode, Scott Becker shares why the most successful teams are built on a thrive thrive culture, where individual strengths and company needs align even without perfect overlap.
In this episode, Scott Becker discusses Bitcoin’s drop from its recent peak near $126,000 to the mid $60,000 range as risk sentiment weakens, leveraged bets unwind, and the government signals no crypto bailouts.
In this episode, Scott Becker walks through the year to date performance of several closely followed stocks including Intel, Coca-Cola, Bank of America, UnitedHealth Group, and Palantir.
In this episode, Scott Becker break down Peloton's disappointing earnings report with revenue falling short of expectations and weak future guidance, continuing a sharp multiyear decline in sales and stock performance.
In this episode, Scott Becker shares quick takes on Oracle, Bitcoin, Lululemon, and Lucid Motors, breaking down steep year to date and one year declines and what is driving the pullback in each.
In this episode, Alan Condon, Editor in Chief at Becker's Healthcare, joins Scott Becker to break down major revenue cycle developments, including Tenet regaining full control of Conifer Health Solutions and new RCM platforms targeting rural providers.
In this episode, Scott Becker outlines 5 troubling signals in the economy, including sharply lower job creation, major media layoffs, and more.
In this episode, Laura Dyrda, Vice President and Editor in Chief of Becker's Healthcare, joins Scott Becker to discuss how Community Health Systems and CommonSpirit Health are pruning portfolios and simplifying operations to strengthen performance. She also shares insights on Oracle's expansion of clinical AI to reduce clinician burden and improve care delivery.
In this episode, Scott Becker reflects on his personal experience investing in private equity and venture capital, comparing expectations with reality and exploring the idea of being the dog who caught the car.
In this episode, Scott Becker reviews the YTD performance of the largest private equity and alternative asset managers, ranking Carlyle, Apollo, Blackstone, TPG, and KKR from best to worst.
In this episode, Chris Lacy, President at Priority Search Management, joins Scott Becker to share practical insights on hiring, onboarding, and why companies often overlook the critical “missing middle” below the executive level.
In this episode, Scott Becker reviews 6 key developments, including Providence Mission Hospital's plan to phase out acute care, growing tension between health systems and Medicare Advantage plans, multiple hospital leadership changes, and more.
In this episode, Scott Becker breaks down the year to date performance of the Magnificent 7, highlighting gains and losses across Meta, Tesla, Apple, Microsoft, and others.
In this episode, David Pivnick, Partner at McGuireWoods LLP, joins Scott Becker to share practical insights on what separates top performers from the rest, from consistency and responsiveness to ownership and self reflection.
In this episode, Scott Becker covers Apple's $143 billion quarter powered by record iPhone sales, while the stock slipped amid concerns about margin pressure and slowing growth.
In this episode, Scott Becker shares insights into Microsoft's sharp stock decline, Meta's rebound, healthcare payers, Starbucks, the Fed, and more.
In this webinar turned podcast, Molly Gamble joins Scott Becker to share insights into the book they co-authored “Building Great Businesses: Create Momentum, Overcome Setbacks & Scale with Confidence”.
In this episode, Scott Becker explains Microsoft's roughly 12% drop despite solid earnings, driven by slower cloud growth and high market expectations.
In this episode, Scott Becker reflects on why strong income years can create a false sense of permanence and encourages saving early to take full advantage of compounding.
In this episode, Scott Becker explains Microsoft's roughly 12% drop despite solid earnings, driven by slower cloud growth and high market expectations.
In this episode, Scott Becker reflects on why strong income years can create a false sense of permanence and encourages saving early to take full advantage of compounding.
In this episode, Scott Becker highlights Starbucks' turnaround in customer experience, Amazon's push to improve margins through layoffs, and how Apple and Epic exemplify the power of relentless, incremental improvement.
In this episode, Scott Becker breaks down UnitedHealthcare's sharp stock drop, strong recent earnings, and troubling signals including projected revenue decline, rising medical loss ratios, and shrinking Medicare and Medicaid enrollment.
In this episode, Scott Becker breaks down UnitedHealthcare's sharp stock drop, strong recent earnings, and troubling signals including projected revenue decline, rising medical loss ratios, and shrinking Medicare and Medicaid enrollment.
In this episode, Jakob Emerson, Associate News Director at Becker's Healthcare, joins Scott Becker to break down a brutal week for payers, marked by plunging stocks, Medicare Advantage rate pressure, and intense congressional scrutiny.
In this episode, Scott Becker highlights Starbucks' turnaround in customer experience, Amazon's push to improve margins through layoffs, and how Apple and Epic exemplify the power of relentless, incremental improvement.
In this episode, Scott Becker breaks down UnitedHealthcare's sharp stock drop, strong recent earnings, and troubling signals including projected revenue decline, rising medical loss ratios, and shrinking Medicare and Medicaid enrollment.
In this episode, Scott Becker speaks with Amber Walsh of McGuireWoods LLP, about the economic impact of major storms, from GDP losses to business disruption, and how weather risk is influencing healthcare investing and private equity diligence.
In this episode, Scott Becker discusses UnitedHealthcare’s drop on lower revenue expectations while Alphabet, Nvidia, and other mega cap tech stocks continue to shape the market narrative.
In this episode, Alan Condon, Editor in Chief at Becker's Healthcare, joins Scott Becker to discuss major health system earnings, including HCA's strong financial performance, along with ongoing divestitures and turnaround strategies at Community Health Systems, CommonSpirit, Providence, and other large systems.
In this episode, Scott Becker speaks with Amber Walsh of McGuireWoods LLP, about the economic impact of major storms, from GDP losses to business disruption, and how weather risk is influencing healthcare investing and private equity diligence.
In this episode, Scott Becker discusses UnitedHealthcare’s drop on lower revenue expectations while Alphabet, Nvidia, and other mega cap tech stocks continue to shape the market narrative.
In this episode, Scott Becker discusses why Alphabet continues to look like a compelling growth stock ahead of its upcoming earnings report.
In this episode, Scott Becker highlights 10 key healthcare stories, including oncology's foundations, hospital responses to winter storms, major system divestitures, rural hospital funding, staffing ratios, and more.
In this episode, Scott Becker discusses why Alphabet continues to look like a compelling growth stock ahead of its upcoming earnings report.
In this episode, Scott Becker breaks down Apple's massive cash flow and iconic brand strength, while questioning whether its high price to earnings ratio is justified by slowing growth.
In this episode, Scott Becker highlights the value of colleagues who require minimal supervision and consistently deliver results, creating true leverage for leaders.
In this episode, Scott Becker highlights the value of colleagues who require minimal supervision and consistently deliver results, creating true leverage for leaders.
In this episode, Scott Becker discusses Intel’s shares drop sharply after a weaker than expected revenue and earnings outlook, wiping out much of the stock's recent gains despite a strong yearlong turnaround.
In this episode, Scott Becker discusses President Trump's $5 billion lawsuit against J.P. Morgan Chase and Jamie Dimon.
In this episode, Scott Becker speaks with Molly Gamble, Vice President of Editorial at Becker's Healthcare, about key insights from the JPM Healthcare Conference, including the shift away from hospital-centric models, growing capacity pressures, early results from AI investments, and the evolving reality of value-based care.
In this episode, Scott Becker reflects on how market swings test investor discipline and the temptation to shift asset allocations after strong runs or sudden drops.
In this episode, Scott Becker discusses Intel's sharp turnaround and stock surge, a market rebound tied to easing geopolitical tensions, and GDP growth accelerating to a 4.4% pace.
In this episode, Scott Becker covers a turbulent day in the markets, pressure on private equity exits, and notable stock moves across technology, healthcare, and travel.
In this episode, Scott Becker examines Beyond Meat's steep 80% decline over the past year and its move into protein drinks.
In this episode, Scott Becker reviews 7 major developments in healthcare, including nurse strikes, IT risks, major cancer center investments, rural hospital recovery, and more.
In this episode, Scott Becker breaks down Porsche's nearly 10% sales decline, driven by a tough China market and slower than expected electric vehicle momentum.
In this episode, Scott Becker covers the breakup between Saks and Amazon, slowing Porsche sales, Beyond Meat's pivot, and recent moves across Meta, Apple, Walmart, and DraftKings.
In this episode, Scott Becker discusses Circle Internet's recent drop, reflections on investor inertia, and what it feels like to hold declining assets.